TreeWAS – Variant ID: rs11683229

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D22.6 Melanocytic naevi of upper limb, including shoulder	0.014	0.986	0.000
D22.0 Melanocytic naevi of lip	0.012	0.988	0.000
D22.4 Melanocytic naevi of scalp and neck	0.012	0.988	0.000
D22 Melanocytic naevi	0.012	0.988	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.989	0.011
M47.86 Other spondylosis (Lumbar region)	0.011	0.989	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.990	0.010
D22.7 Melanocytic naevi of lower limb, including hip	0.010	0.990	0.000
T39.1 4-Aminophenol derivatives	0.000	0.991	0.009
D22.2 Melanocytic naevi of ear and external auricular canal	0.009	0.991	0.000
D22.9 Melanocytic naevi, unspecified	0.008	0.991	0.000
T39.0 Salicylates	0.000	0.992	0.008
D22.1 Melanocytic naevi of eyelid, including canthus	0.008	0.992	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.993	0.007
T39.2 Pyrazolone derivatives	0.000	0.993	0.007
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.993	0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.993	0.007
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.993	0.007
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.993	0.007
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.993	0.006
D22.5 Melanocytic naevi of trunk	0.006	0.994	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.994	0.006
C67.9 Bladder, unspecified	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.994	0.006
T40.4 Other synthetic narcotics	0.000	0.994	0.006
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.995	0.005
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.005	0.995	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.005	0.995	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.995	0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.995	0.005
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.995	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.995	0.005
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.995	0.005
T46.1 Calcium-channel blockers	0.000	0.995	0.005
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.995	0.005
T43.9 Psychotropic drug, unspecified	0.000	0.995	0.005
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.995	0.005
T43.6 Psychostimulants with abuse potential	0.000	0.995	0.005
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.995	0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.995	0.005
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.995	0.005
T36 Poisoning by systemic antibiotics	0.000	0.995	0.005
T40.2 Other opioids	0.000	0.995	0.005
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.995	0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.995	0.005
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.995	0.005
T40.8 Lysergide [LSD]	0.000	0.995	0.005
T40.7 Cannabis (derivatives)	0.000	0.995	0.005
T40.5 Cocaine	0.000	0.995	0.005
T40.3 Methadone	0.000	0.995	0.005
T40.1 Heroin	0.000	0.995	0.005
T40.0 Opium	0.000	0.995	0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.995	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.995	0.004
T46.7 Peripheral vasodilators	0.000	0.995	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.995	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.995	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.995	0.004
T43.2 Other and unspecified antidepressants	0.000	0.995	0.005
T45.5 Anticoagulants	0.000	0.995	0.004
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.996	0.004
N43.3 Hydrocele, unspecified	0.000	0.996	0.004
T40.6 Other and unspecified narcotics	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.996	0.004
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.004
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.004
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.004
T45.4 Iron and its compounds	0.000	0.996	0.004
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.004
T45.2 Vitamins, not elsewhere classified	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.004
D09.0 Bladder	0.004	0.996	0.000
M41.9 Scoliosis, unspecified	0.004	0.996	0.000
C67.4 Posterior wall of bladder	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.004
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
T47.7 Emetics	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.000	0.996	0.004
T47.5 Digestants	0.000	0.996	0.004
T47.4 Other laxatives	0.000	0.996	0.004
T47.3 Saline and osmotic laxatives	0.000	0.996	0.004
T47.2 Stimulant laxatives	0.000	0.996	0.004
T47.0 Histamine H(2)-receptor antagonists	0.000	0.996	0.004
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.996	0.004
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.996	0.004
T37.5 Antiviral drugs	0.000	0.996	0.004
T37.4 Anthelminthics	0.000	0.996	0.004
T37.3 Other antiprotozoal drugs	0.000	0.996	0.004
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.996	0.004
T37.1 Antimycobacterial drugs	0.000	0.996	0.004
T37.0 Sulphonamides	0.000	0.996	0.004
T41.5 Therapeutic gases	0.000	0.996	0.004
T41.4 Anaesthetic, unspecified	0.000	0.996	0.004
T41.3 Local anaesthetics	0.000	0.996	0.004
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.004
T41.1 Intravenous anaesthetics	0.000	0.996	0.004
T41.0 Inhaled anaesthetics	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.004
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.004
T48.5 Anti-common-cold drugs	0.000	0.996	0.004
T48.4 Expectorants	0.000	0.996	0.004
T48.3 Antitussives	0.000	0.996	0.004
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.004
T48.0 Oxytocic drugs	0.000	0.996	0.004
T49.9 Topical agent, unspecified	0.000	0.996	0.004
T49.8 Other topical agents	0.000	0.996	0.004
T49.7 Dental drugs, topically applied	0.000	0.996	0.004
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.004
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.004
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.004
T49.2 Local astringents and local detergents	0.000	0.996	0.004
T49.1 Antipruritics	0.000	0.996	0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.004
T38.9 Other and unspecified hormone antagonists	0.000	0.996	0.004
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.996	0.004
T38.7 Androgens and anabolic congeners	0.000	0.996	0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.996	0.004
T38.5 Other oestrogens and progestogens	0.000	0.996	0.004
T38.4 Oral contraceptives	0.000	0.996	0.004
T38.2 Antithyroid drugs	0.000	0.996	0.004
T38.0 Glucocorticoids and synthetic analogues	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
T36.9 Systemic antibiotic, unspecified	0.000	0.996	0.004
T36.8 Other systemic antibiotics	0.000	0.996	0.004
T36.7 Antifungal antibiotics, systemically used	0.000	0.996	0.004
T36.6 Rifamycins	0.000	0.996	0.004
T36.5 Aminoglycosides	0.000	0.996	0.004
T36.4 Tetracyclines	0.000	0.996	0.004
T36.3 Macrolides	0.000	0.996	0.004
T36.2 Chloramphenicol group	0.000	0.996	0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.996	0.004
D03.3 Melanoma in situ of other and unspecified parts of face	0.004	0.996	0.000
T36.0 Penicillins	0.000	0.996	0.004
C67 Malignant neoplasm of bladder	0.004	0.996	0.000
D04 Carcinoma in situ of skin	0.004	0.996	0.000
D09 Carcinoma in situ of other and unspecified sites	0.004	0.996	0.000
D03 Melanoma in situ	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
T44.0 Anticholinesterase agents	0.000	0.996	0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.004	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.003
E14.9 Without complications	0.004	0.996	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.004	0.996	0.000
D04.6 Skin of upper limb, including shoulder	0.004	0.996	0.000
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung	0.000	0.996	0.004
D04.9 Skin, unspecified	0.003	0.996	0.000
C67.5 Bladder neck	0.003	0.997	0.000
D04.5 Skin of trunk	0.003	0.997	0.000
D00-D09 In situ neoplasms	0.003	0.997	0.000
D04.3 Skin of other and unspecified parts of face	0.003	0.997	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
E14 Unspecified diabetes mellitus	0.003	0.997	0.000
E14.3 With ophthalmic complications	0.003	0.997	0.000
D09.1 Other and unspecified urinary organs	0.003	0.997	0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.003	0.997	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.003	0.997	0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.003	0.997	0.000
M41.92 Scoliosis, unspecified (Cervical region)	0.003	0.997	0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.003	0.997	0.000
C25.9 Pancreas, unspecified	0.000	0.997	0.003
M41.99 Scoliosis, unspecified (Site unspecified)	0.003	0.997	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.003	0.997	0.000
Z95.3 Presence of xenogenic heart valve	0.003	0.997	0.000
D04.1 Skin of eyelid, including canthus	0.003	0.997	0.000
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
D01 Carcinoma in situ of other and unspecified digestive organs	0.003	0.997	0.000
D04.4 Skin of scalp and neck	0.003	0.997	0.000
E14.1 With ketoacidosis	0.003	0.997	0.000
J34.0 Abscess, furuncle and carbuncle of nose	0.003	0.997	0.000
C67.7 Urachus	0.003	0.997	0.000
C67.2 Lateral wall of bladder	0.003	0.997	0.000
C67.0 Trigone of bladder	0.003	0.997	0.000
D04.8 Skin of other sites	0.003	0.997	0.000
D04.2 Skin of ear and external auricular canal	0.003	0.997	0.000
D04.0 Skin of lip	0.003	0.997	0.000
D09.9 Carcinoma in situ, unspecified	0.003	0.997	0.000
D09.7 Carcinoma in situ of other specified sites	0.003	0.997	0.000
D09.3 Thyroid and other endocrine glands	0.003	0.997	0.000
D09.2 Eye	0.003	0.997	0.000
D03.9 Melanoma in situ, unspecified	0.003	0.997	0.000
D03.8 Melanoma in situ of other sites	0.003	0.997	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.003	0.997	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.003	0.997	0.000
D03.0 Melanoma in situ of lip	0.003	0.997	0.000
I78.1 Naevus, nonneoplastic	0.000	0.997	0.003
Z90.2 Acquired absence of lung [part of]	0.000	0.997	0.003
C67.8 Overlapping lesion of bladder	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.997	0.003
D01.0 Colon	0.003	0.997	0.000
D03.5 Melanoma in situ of trunk	0.003	0.997	0.000
D03.4 Melanoma in situ of scalp and neck	0.003	0.997	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.003	0.997	0.000
E14.8 With unspecified complications	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
D06 Carcinoma in situ of cervix uteri	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.002
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.003	0.997	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.003	0.997	0.000
B35.3 Tinea pedis	0.003	0.997	0.000
C67.3 Anterior wall of bladder	0.003	0.997	0.000
E14.7 With multiple complications	0.003	0.997	0.000
E14.6 With other specified complications	0.003	0.997	0.000
E14.5 With peripheral circulatory complications	0.003	0.997	0.000
E14.4 With neurological complications	0.003	0.997	0.000
E14.2 Withrenal complications	0.003	0.997	0.000
E14.0 With coma	0.003	0.997	0.000
I89.0 Lymphoedema, not elsewhere classified	0.003	0.997	0.000
M41 Scoliosis	0.003	0.997	0.000
D01.9 Digestive organ, unspecified	0.002	0.997	0.000
D01.7 Other specified digestive organs	0.002	0.997	0.000
D01.5 Liver, gallbladder and bile ducts	0.002	0.997	0.000
D01.4 Other and unspecified parts of intestine	0.002	0.997	0.000
D01.3 Anus and anal canal	0.002	0.997	0.000
D01.2 Rectum	0.002	0.997	0.000
D01.1 Rectosigmoid junction	0.002	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.002
C67.1 Dome of bladder	0.002	0.998	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.998	0.002
M41.8 Other forms of scoliosis	0.002	0.998	0.000
T42.1 Iminostilbenes	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.998	0.002
D06.9 Cervix, unspecified	0.002	0.998	0.000
M41.86 Other forms of scoliosis (Lumbar region)	0.002	0.998	0.000
D00.0 Lip, oral cavity and pharynx	0.002	0.998	0.000
D04.7 Skin of lower limb, including hip	0.002	0.998	0.000
D06.7 Other parts of cervix	0.002	0.998	0.000
D06.1 Exocervix	0.002	0.998	0.000
D06.0 Endocervix	0.002	0.998	0.000
D00.2 Stomach	0.002	0.998	0.000
D00.1 Oesophagus	0.002	0.998	0.000
E87.7 Fluid overload	0.002	0.998	0.000
D02.4 Respiratory system, unspecified	0.002	0.998	0.000
D02.3 Other parts of respiratory system	0.002	0.998	0.000
D02.2 Bronchus and lung	0.002	0.998	0.000
D02.1 Trachea	0.002	0.998	0.000
D02.0 Larynx	0.002	0.998	0.000
E10.4 With neurological complications	0.002	0.998	0.000
H53.1 Subjective visual disturbances	0.002	0.998	0.000
R82.9 Other and unspecified abnormal finding in urine	0.002	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.998	0.002
G50.0 Trigeminal neuralgia	0.000	0.998	0.002
I49.9 Cardiac arrhythmia, unspecified	0.002	0.998	0.000
K26.3 Acute without haemorrhage or perforation	0.002	0.998	0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.002	0.998	0.000
C67.6 Ureteric orifice	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
M47.8 Other spondylosis	0.002	0.998	0.000
M41.5 Other secondary scoliosis	0.002	0.998	0.000
M41.4 Neuromuscular scoliosis	0.002	0.998	0.000
M41.3 Thoracogenic scoliosis	0.002	0.998	0.000
M41.2 Other idiopathic scoliosis	0.002	0.998	0.000
M41.1 Juvenile idiopathic scoliosis	0.002	0.998	0.000
M41.0 Infantile idiopathic scoliosis	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
C44.7 Skin of lower limb, including hip	0.002	0.998	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.002	0.998	0.000
C25.0 Head of pancreas	0.000	0.998	0.002
C68.0 Urethra	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
D22.3 Melanocytic naevi of other and unspecified parts of face	0.002	0.998	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.998	0.002
C25 Malignant neoplasm of pancreas	0.000	0.998	0.002
M47.87 Other spondylosis (Lumbosacral region)	0.002	0.998	0.000
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)	0.000	0.998	0.002
I89.1 Lymphangitis	0.002	0.998	0.000
M41.89 Other forms of scoliosis (Site unspecified)	0.002	0.998	0.000
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.87 Other forms of scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.85 Other forms of scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.84 Other forms of scoliosis (Thoracic region)	0.002	0.998	0.000
M41.83 Other forms of scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.82 Other forms of scoliosis (Cervical region)	0.002	0.998	0.000
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.80 Other forms of scoliosis (Multiple sites in spine)	0.002	0.998	0.000
K26.4 Chronic or unspecified with haemorrhage	0.002	0.998	0.000
O75.7 Vaginal delivery following previous Caesarean section	0.002	0.998	0.000
Y84.6 Urinary catheterisation	0.002	0.998	0.000
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.002	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.002	0.998	0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.002	0.998	0.000
M54.57 Low back pain (Lumbosacral region)	0.002	0.998	0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.000	0.998	0.002
B35.1 Tinea unguium	0.002	0.998	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.000	0.998	0.002
Z42.0 Follow-up care involving plastic surgery of head and neck	0.002	0.998	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.002	0.998	0.000
R82 Other abnormal findings in urine	0.002	0.998	0.000
G47.3 Sleep apnoea	0.002	0.998	0.000
M65.4 Radial styloid tenosynovitis [de Quervain]	0.000	0.998	0.002
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.998	0.002
N86 Erosion and ectropion of cervix uteri	0.000	0.998	0.002
Y84.0 Cardiac catheterisation	0.002	0.998	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.002	0.998	0.000
O82.0 Delivery by elective Caesarean section	0.000	0.998	0.002
M47.85 Other spondylosis (Thoracolumbar region)	0.002	0.998	0.000
M47.83 Other spondylosis (Cervicothoracic region)	0.002	0.998	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.998	0.002
C85.0 Lymphosarcoma	0.000	0.998	0.002
N90.4 Leukoplakia of vulva	0.002	0.998	0.000
B35 Dermatophytosis	0.002	0.998	0.000
C25.2 Tail of pancreas	0.000	0.998	0.002
S29.9 Unspecified injury of thorax	0.002	0.998	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.002	0.998	0.000
M41.09 Infantile idiopathic scoliosis (Site unspecified)	0.002	0.998	0.000
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.06 Infantile idiopathic scoliosis (Lumbar region)	0.002	0.998	0.000
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.04 Infantile idiopathic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.02 Infantile idiopathic scoliosis (Cervical region)	0.002	0.998	0.000
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.19 Juvenile idiopathic scoliosis (Site unspecified)	0.002	0.998	0.000
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.16 Juvenile idiopathic scoliosis (Lumbar region)	0.002	0.998	0.000
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.14 Juvenile idiopathic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.12 Juvenile idiopathic scoliosis (Cervical region)	0.002	0.998	0.000
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.29 Other idiopathic scoliosis (Site unspecified)	0.002	0.998	0.000
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.27 Other idiopathic scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.26 Other idiopathic scoliosis (Lumbar region)	0.002	0.998	0.000
M41.25 Other idiopathic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.24 Other idiopathic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.23 Other idiopathic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.22 Other idiopathic scoliosis (Cervical region)	0.002	0.998	0.000
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.20 Other idiopathic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.39 Thoracogenic scoliosis-Site unspe	0.002	0.998	0.000
M41.38 Thoracogenic scoliosis-Sacral/sacrococ	0.002	0.998	0.000
M41.37 Thoracogenic scoliosis-Lumbosacral	0.002	0.998	0.000
M41.36 Thoracogenic scoliosis-Lumbar	0.002	0.998	0.000
M41.35 Thoracogenic scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.34 Thoracogenic scoliosis (Thoracic region)	0.002	0.998	0.000
M41.33 Thoracogenic scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.32 Thoracogenic scoliosis-Cervical	0.002	0.998	0.000
M41.31 Thoracogenic scoliosis-Occipit-atl-axl	0.002	0.998	0.000
M41.30 Thoracogenic scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.49 Neuromuscular scoliosis (Site unspecified)	0.002	0.998	0.000
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.47 Neuromuscular scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.46 Neuromuscular scoliosis (Lumbar region)	0.002	0.998	0.000
M41.45 Neuromuscular scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.44 Neuromuscular scoliosis (Thoracic region)	0.002	0.998	0.000
M41.43 Neuromuscular scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.42 Neuromuscular scoliosis (Cervical region)	0.002	0.998	0.000
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.40 Neuromuscular scoliosis (Multiple sites in spine)	0.002	0.998	0.000
M41.59 Other secondary scoliosis (Site unspecified)	0.002	0.998	0.000
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M41.57 Other secondary scoliosis (Lumbosacral region)	0.002	0.998	0.000
M41.56 Other secondary scoliosis (Lumbar region)	0.002	0.998	0.000
M41.55 Other secondary scoliosis (Thoracolumbar region)	0.002	0.998	0.000
M41.54 Other secondary scoliosis (Thoracic region)	0.002	0.998	0.000
M41.53 Other secondary scoliosis (Cervicothoracic region)	0.002	0.998	0.000
M41.52 Other secondary scoliosis (Cervical region)	0.002	0.998	0.000
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M41.50 Other secondary scoliosis (Multiple sites in spine)	0.002	0.998	0.000
N99.2 Postprocedural adhesions of vagina	0.000	0.998	0.002
K41 Femoral hernia	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.002	0.998	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M47.84 Other spondylosis (Thoracic region)	0.002	0.998	0.000
E10.8 With unspecified complications	0.002	0.998	0.000
E10.0 With coma	0.002	0.998	0.000
C25.8 Overlapping lesion of pancreas	0.000	0.998	0.002
C25.7 Other parts of pancreas	0.000	0.998	0.002
C25.4 Endocrine pancreas	0.000	0.998	0.002
C25.1 Body of pancreas	0.000	0.998	0.002
C65 Malignant neoplasm of renal pelvis	0.002	0.998	0.000
E10 Insulin-dependent diabetes mellitus	0.002	0.998	0.000
E10.5 With peripheral circulatory complications	0.002	0.998	0.000
E10.3 With ophthalmic complications	0.002	0.998	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.002	0.998	0.000
K75.4 Autoimmune hepatitis	0.002	0.998	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.002	0.998	0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.000	0.998	0.002
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.000	0.998	0.002
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.000	0.998	0.002
I49.4 Other and unspecified premature depolarisation	0.002	0.998	0.000
K75.0 Abscess of liver	0.002	0.998	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.002	0.998	0.000
R82.4 Acetonuria	0.002	0.998	0.000
R82.3 Haemoglobinuria	0.002	0.998	0.000
R82.2 Biliuria	0.002	0.998	0.000
R82.1 Myoglobinuria	0.002	0.998	0.000
R82.0 Chyluria	0.002	0.998	0.000
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec	0.000	0.998	0.001
M65.48 Radial styloid tenosynovitis [de Quervain]-Other	0.000	0.998	0.001
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot	0.000	0.998	0.001
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg	0.000	0.998	0.001
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh	0.000	0.998	0.001
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm	0.000	0.998	0.001
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region	0.000	0.998	0.001
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)	0.000	0.998	0.001
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
D07.6 Other and unspecified male genital organs	0.001	0.998	0.000
D07.4 Penis	0.001	0.998	0.000
D07.3 Other and unspecified female genital organs	0.001	0.998	0.000
D07.0 Endometrium	0.001	0.998	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.998	0.002
C25.3 Pancreatic duct	0.000	0.998	0.001
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.998	0.002
M07.3 Other psoriatic arthropathies	0.002	0.998	0.000
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.998	0.002
C64-C68 Malignant neoplasms of urinary tract	0.002	0.998	0.000
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.000	0.998	0.002
K26 Duodenal ulcer	0.002	0.998	0.000
B35.9 Dermatophytosis, unspecified	0.001	0.998	0.000
B35.8 Other dermatophytoses	0.001	0.998	0.000
B35.6 Tinea cruris	0.001	0.998	0.000
B35.5 Tinea imbricata	0.001	0.998	0.000
B35.4 Tinea corporis	0.001	0.998	0.000
B35.2 Tinea manuum	0.001	0.998	0.000
B35.0 Tinea barbae and tinea capitis	0.001	0.998	0.000
I49.0 Ventricular fibrillation and flutter	0.000	0.998	0.001
N99.5 Malfunction of external stoma of urinary tract	0.000	0.998	0.002
I78 Diseases of capillaries	0.000	0.998	0.002
K75 Other inflammatory liver diseases	0.002	0.998	0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.000	0.998	0.002
C68.9 Urinary organ, unspecified	0.001	0.998	0.000
C68.8 Overlapping lesion of urinary organs	0.001	0.998	0.000
C68.1 Paraurethral glands	0.001	0.998	0.000
D07.1 Vulva	0.001	0.998	0.000
D07.2 Vagina	0.001	0.998	0.000
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.001	0.998	0.000
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.001	0.998	0.000
K41.1 Bilateral femoral hernia, with gangrene	0.001	0.998	0.000
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.001	0.998	0.000
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.001	0.998	0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.000	0.998	0.001
K26.7 Chronic without haemorrhage or perforation	0.002	0.998	0.000
O80.9 Single spontaneous delivery, unspecified	0.002	0.998	0.000
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.001	0.998	0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.998	0.001
E10.7 With multiple complications	0.001	0.998	0.000
Z51.3 Blood transfusion without reported diagnosis	0.000	0.998	0.002
M54.50 Low back pain (Multiple sites in spine)	0.001	0.998	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.001	0.999	0.000
E10-E14 Diabetes mellitus	0.001	0.999	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.000	0.999	0.001
Z34.8 Supervision of other normal pregnancy	0.001	0.999	0.000
M07.38 Other psoriatic arthropathies (Other)	0.001	0.999	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.001	0.999	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.001	0.999	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.001	0.999	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.001	0.999	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.001	0.999	0.000
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.999	0.001
M47.80 Other spondylosis (Multiple sites in spine)	0.001	0.999	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.999	0.001
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.001	0.999	0.000
K26.2 Acute with both haemorrhage and perforation	0.001	0.999	0.000
K26.1 Acute with perforation	0.001	0.999	0.000
I78.9 Disease of capillaries, unspecified	0.000	0.999	0.001
K75.3 Granulomatous hepatitis, not elsewhere classified	0.001	0.999	0.000
K75.2 Nonspecific reactive hepatitis	0.001	0.999	0.000
K75.1 Phlebitis of portal vein	0.001	0.999	0.000
E55.9 Vitamin D deficiency, unspecified	0.001	0.999	0.000
G25.0 Essential tremor	0.001	0.999	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.999	0.001
T42.4 Benzodiazepines	0.000	0.999	0.001
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.001	0.999	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations